RF30 | PSAT172 Effects of 12 Months of Alendronate Therapy Subsequent to 12 Months of Denosumab Administration in Women With Anorexia Nervosa

Low bone mineral density (BMD) and increased fracture risk are common complications of anorexia nervosa. We assessed whether 12 months of alendronate subsequent to 12 months of denosumab would 1) maintain the increases in BMD observed with denosumab and 2) result in higher BMD than alendronate for 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Haines, Melanie, Kimball, Allison, Meenaghan, Erinne, Strauch, Julianne, Colling, Caitlin, Singhal, Vibha, Eddy, Kamryn, Misra, Madhusmita, Miller, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Bone & Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707031/
http://dx.doi.org/10.1210/jendso/bvac150.476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707031/
http://dx.doi.org/10.1210/jendso/bvac150.476

Ejemplares similares